The Finance and Accounting team at Iovance Biotherapeutics is responsible for managing the company's financial health and ensuring accurate reporting. This team oversees financial planning and analysis, consolidates global financial data, and ensures compliance with accounting standards. By providing strategic insights and maintaining effective financial controls, they support the organization’s mission to innovate in cancer treatment through T cell-based therapies.
Anh Doan
Staff Accountant
Emilie Amorim
Vice President, Global Fp&a
Irina Cho
Assistant Corporate Controller
Jackie Holcomb (Suzu...
VP Of Finance, Corporate Contr...
Jean-Marc Bellemin
CFO
Matthew Rosinack
Senior Vice President Finance
Shanna Wu
Manager, Global Consolidation
Sumitra Rathi
Accountant II
Tom Torre
Senior Vice President Finance ...
Wayland Wong
Associate Director, Financial ...
View all